Disable Preloader
Disable Preloader

Ε.Ε.Π.Α.Ο.

  • Νέα εγγραφή / Είσοδος

Νέα και Αρθρα της Ε.Ε.Π.Α.Ο.

CALL FOR ABSTRACTS REMINDER - 10th Biennial Childhood Leukemia Symposium

CALL FOR ABSTRACTS REMINDER - 10th Biennial Childhood Leukemia Symposium

The Scientific committee of the 10th Biennial Childhood Leukemia Symposium, to be held together with the 27th Annual Meeting of the International BFM Study Group in Megaron Athens International Conference Center,  April 25 - 26, 2016, would like to remind you that the deadline for Abstract Submission is approaching. As communicated to you previously, the deadline is set for date January 12, 2016.

Follow the website for the latest news about the symposium.

Please make sure to consult the Abstract submission guidelines prior to submitting your abstract online.

Take an active part in the scientific programme of the upcoming symposium
and submit your abstract here:

ONLINE ABSTRACT SUBMISSION

Should you have any questions or should you encounter any difficulties while submitting your abstract, do not hesitate to contact us.

We are looking forward to your contributions!

Kind regards,

CLS 2016 Symposium Secretariat

ΤΕΛΕΥΤΑΙΑ ΝΕΑ

Ενημερωθείτε για τις δράσεις και τα νέα της E.E.P.A.O.

ΣΑΒΒΑΤΟ 22 ΟΚΤΩΒΡΙΟΥ 2022

ώρα έναρξης τελετής 17:00

Φιλανθρωπική, Αθλητική Εκδήλωση

ΤΡΕΧΟΥΜΕ ΕΝΑΝΤΙΑ ΣΤΟΝ

ΠΑΙΔΙΚΟ ΚΑΡΚΙΝΟ

Δώστε ΠΙΣΤΗ στον αγώνα των παιδιών για ζωή

Περισσότερα

Blood and Beyond welcomes the Commission’s proposal to revise the Blood, Tissue and Cells directive and shares recommendations to support the legislative process On October 5, the Blood and Beyond initiative published a statement in response to the European Commission’s proposal for the Blood, Tissue and Cells Directive revision published on 14 July. Blood and Beyond welcomes the Commission’s proposal, in particular the focused objectives to facilitate the development of SoHO therapies and blood sector innovation that improves health outcomes; and to strengthen systems to provide safe and adequate allogenic blood, which is vital for patients who have no alternative treatment options. Blood and Beyond shared the following recommendations on the Commission’s proposal:

Περισσότερα

Copyright© Ε.Ε.Π.Α.Ο.PROFILGROUP All right reserved.